Search results for: 'Social Networking Markets'

This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the A...

23 Aug 2022  |  North America  |  Market Research

Global Bioanalytical Testing Services, 2021–2027

Acquisition of Disruptive Technologies will be the Key to Driving Growth

Infographics

×

Key Issues Addressed

As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug dev...

07 Aug 2024  |  Global  |  Market Research

Non-surgical Healthcare Robots Sector, Global, 2024 2028

Regulatory Approvals, Reimbursement Policies, and Leasing Plans Are Driving Transformational Growth by Supporting Healthcare Centers in Implementing Hospital Operations, Nursing Assistant, and Patient Assistant Robots

Infographics

×

Key Benefits

This Frost & Sullivan analysis covers innovative devices propelling industry growth as well as market trends and emerging business models that will dominate the non-surgical healthcare robots sector. Highlights include a look at cutting-edge solutions in the non-surgical healthcare robots industry, including hospital operations robots, nursing assi...

This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...

This study charts how digital health ecosystems are likely to form and scale through 2040 and what that implies for providers, payers, technology vendors, and retail/community partners. We define a digital health ecosystem as an interoperable platform that coordinates people, data, and decisions across home, retail, and hospital settings—secured by...

Telemedicine Markets in Sub-Saharan Africa offers comprehensive analysis of the telemedicine landscape in key Sub-Saharan African countries. The South African telemedicine market forms the core of this study. In addition, case studies of four key countries are presented. The study provides an overview of the main initiatives in South Africa, and an...

Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...

The global medical imaging equipment and informatics market is experiencing a surge in innovative manufacturing and supply chain management techniques that enable the uninterrupted supply of imaging equipment. In addition, cloud-based artificial intelligence (AI) capabilities, advanced analytics, and AI/machine learning drive the adoption of enterp...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...